000 01180 a2200313 4500
005 20250517085727.0
264 0 _c20160727
008 201607s 0 0 eng d
022 _a1572-0241
024 7 _a10.1038/ajg.2015.412
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aArchibugi, Livia
245 0 0 _aStatin Use and Survival in Resectable Pancreatic Cancer: Confounders and Mechanisms.
_h[electronic resource]
260 _bThe American journal of gastroenterology
_cMar 2016
300 _a436 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aCarcinoma, Pancreatic Ductal
_xmortality
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xadministration & dosage
650 0 4 _aLovastatin
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aPancreatic Neoplasms
_xmortality
650 0 4 _aSimvastatin
_xadministration & dosage
700 1 _aCapurso, Gabriele
700 1 _aDelle Fave, Gianfranco
773 0 _tThe American journal of gastroenterology
_gvol. 111
_gno. 3
_gp. 436
856 4 0 _uhttps://doi.org/10.1038/ajg.2015.412
_zAvailable from publisher's website
999 _c25867170
_d25867170